The Kwazulu-Natal (KZN) Department of Health has yet again taken disciplinary action against a doctor without good reason, this time Dr Mark Blaylock of Manguzi hospital.
The Advertising Standards Authority of South Africa (ASASA) has upheld a complaint by the Treatment Action Campaign against an advertisement for the fake AIDS cure, Ubhejane, placed by Zeblon Gwala in Ilanga newspaper on 6 December 2007.
The ruling is here .
The contents of Ubhejane have never been made public. It has never been tested in clinical trials. It is unregistered and sold illegally as a cure or treatment for HIV.
It is the promotion of one or more of the following pseudo-scientific views: (1) HIV does not cause AIDS, (2) the risks of antiretovirals outweigh their benefits and (3) there is not a large AIDS epidemic in sub-Saharan Africa.
Here we present links to documents debunking these myths. We also present links to documents showing the dire consequences of AIDS denialism.
The Kwazulu-Natal Department of Health has withdrawn its disciplinary action against Dr Colin Pfaff. The TAC welcomes this development.
We agree with Dr Francois Venter, president of the Southern African HIV Clinicians Society who said:
This morning, about 30 members of the TAC, most living openly with HIV, gathered at St Georges Cathedral in Cape Town and proceeded to hand over a complaint against Christine Qunta, her associate Freddie Isaacs and the company Comforter's Healing Gift to the Director of Public Prosecutions, the South African Human Rights Commission and the Cape Law Society. Two TAC members also went to Qunta Incorporated's offices in the Reserve Bank Building to give Chr
A Judicial Investigation into the Presidency and Health Ministry and criminal proceedings against Christine Qunta are necessary.
"34. (1) A person desiring to initiate or conduct a clinical trial
in respect of an unregistered medicine, a new indication or new
dosage regimen of a registered medicine or substance, shall apply to
the Council on a form determined by the Council for authority to
conduct such a clinical trial”.
“(5) No person shall conduct clinical trials referred to in
subregulation (1) without the authorisation of the Council.”